Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 21st October 2020 from 07:00 AM to 07:00 PM (BST).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 12, 2020
Previous Article Next Article

Productive screening of single aptamers with ddPCR

Author affiliations


Antibodies have now been widely used for clinical treatment of a number of tumors. However, there are serious problems associated with antibody therapy, such as potential interactions of antibodies with the immune system as well as long production cycles. Recently, aptamers have been found to function similar to antibodies in terms of affinity and specificity to certain proteins and are attracting much attention for their low immunogenicity, easy chemical synthesis, and efficient penetration into tissues due to their small size. However, how to access high affinity and selectivity aptamers efficiently for further analysis is still open to be resolved. Herein, an aptamer discovery method that combines the continuous flow ddPCR technology with cytometer sorting of beads is reported, such that we have obtained DNA aptamers binding specifically to PD-1 with an affinity of over 60-fold higher than that for the best-reported method.

Graphical abstract: Productive screening of single aptamers with ddPCR

Back to tab navigation

Supplementary files

Article information

06 Mar 2020
04 May 2020
First published
05 May 2020

Analyst, 2020,145, 4130-4137
Article type

Productive screening of single aptamers with ddPCR

J. Chen, J. Wang, Z. Luo, X. Fang, L. He, J. Zhu, Z. Qurat ul ain, J. He, H. Ma, H. Zhang, M. Liu and L. He, Analyst, 2020, 145, 4130
DOI: 10.1039/D0AN00460J

Social activity

Search articles by author